Screener / SEC EDGAR /CIK 0001604821 /10-K filed Feb 27, 2026, compared with Feb 28, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Medical Labs

Natera, Inc. NTRA

Compare with peers Embed
What it said it expected, against what it reported

2 targets with a reported result

Releases of the last 3 years
Above the range 2 above the last range given
Within the range 0 of 2 range targets
Below the range 0 below the last range given

The numbers NTRA said it expected, in its earnings releases, next to what it then reported for the same period.

Target by target

Each target, with the sentence it came from · release and 10-Q or 10-K

The last range givenReported, abovewithin or keptbelow or missed
TargetWhat the company saidReportedResult
Revenue
Fiscal 2026
Given $2.60B to $2.68B release Feb 26, 2026
Raised $2.74B to $2.82B release May 7, 2026
Raised $2.85B to $2.91B release Aug 6, 2026
Raised $3.00B to $3.04B release Nov 5, 2026
– Not reported yet
The company's words
Establishing 2026 financial outlook : revenue of $2.60B - $2.68B; gross margin of 63 % – 65%; and positive cash inflow 2 . release Feb 26, 2026
Raising 2026 annual revenue guidance by $120 million at the midpoint, from $2.62 billion - $2.70 billion to $2.74 billion - $2.82 billion. release May 7, 2026
Raised 2026 annual revenue guidance by $100 million at the midpoint, from $2.74 billion - $2.82 billion to $2.85 billion - $2.91 billion. release Aug 6, 2026
Raised 2026 annual revenue guidance by $140 million at the midpoint, from $2.850 billion - $2.910 billion to $3.005 billion - $3.035 billion. release Nov 5, 2026
Revenue
Fiscal 2025 (ended Dec 31, 2025)
Given $1.87B to $1.95B release Feb 27, 2025
Raised $1.94B to $2.02B release May 8, 2025
Raised $2.02B to $2.10B release Aug 7, 2025
Raised $2.18B to $2.26B release Nov 6, 2025
$2.31B
10-K filed 2026-02-27
Above the range
The company's words
Financial Outlook Natera anticipates 2025 total revenue of $1.87 billion to $1.95 billion; 2025 gross margin to be approximately 60% to 64% of revenues; selling, general and administrative costs to be approximately $950 million to $975 million; research and development costs to be $525 million to $550 million; and net cash inflow to be positive. release Feb 27, 2025
Natera anticipates 2025 total revenue of $1.94 billion to $2.02 billion; 2025 gross margin to be approximately 60% to 64% of revenues; selling, general and administrative costs to be approximately $0.975 billion to $1.05 billion; research and development costs to be $550 million to $590 million; and net cash inflow to be positive. release May 8, 2025
Raising 2025 annual revenue outlook by $80 million at the midpoint, from · $1.94 billion - $2.02 billion to $2.02 billion - $2.10 billion, while maintaining current outlook for operating expenses. release Aug 7, 2025
Raising 2025 annual revenue guidance by $160 · million at the midpoint, from $2.02 billion - $2.10 billion to $2.18 billion - $2.26 billion. release Nov 6, 2025
Revenue
Fiscal 2024 (ended Dec 31, 2024)
Given $1.32B to $1.35B release Feb 28, 2024
Raised $1.42B to $1.45B release May 9, 2024
Raised $1.49B to $1.52B release Aug 8, 2024
Raised $1.61B to $1.64B release Nov 12, 2024
$1.70B
10-K filed 2025-02-28
Above the range
The company's words
Guiding 2024 total revenue of $1.32 billion-$1.35 billion, gross margin release Feb 28, 2024
Raising 2024 guidance: revenue of $1.42B to $1.45B, gross margin of 53% - 55%, cash flow breakeven for 2024. release May 9, 2024
Raising FY2024 guidance: revenues now expected to be $1,490M - $1,520M ; gross margin now expected to be 54% - 56%. release Aug 8, 2024
Raising · annual guidance and now expecting 2024 total revenue of $1.61 to $1.64 billion, gross margin of 58% to 61%, and $50 to $75 million in net cash inflow. release Nov 12, 2024

Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (15 releases since 2024-01-09), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.

Sources

The outlook sentences of each earnings release (8-K item 2.02, exhibit 99), read without AI; results from SEC's XBRL company facts, as first reported.

Also

Earnings releases: each release in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/NTRA/export.csv") into a cell.

Next:Archive
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.